AdaptHealth (NASDAQ:AHCO) Stock Rating Raised to Hold at Wall Street Zen

Wall Street Zen upgraded shares of AdaptHealth (NASDAQ:AHCO) from a sell rating to a hold rating in a research note issued to investors on Saturday morning,Wall Street Zen reports.

AHCO has been the topic of several other research reports. Jefferies Financial Group upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating and lifted their target price for the company from $11.00 to $13.00 in a research report on Tuesday, July 21st. Leerink Partners upped their price target on shares of AdaptHealth from $7.00 to $8.00 and gave the stock an “outperform” rating in a research report on Thursday. Robert W. Baird decreased their price target on shares of AdaptHealth from $10.00 to $9.00 and set an “outperform” rating on the stock in a research note on Thursday, September 17th. Truist Financial lowered their price objective on AdaptHealth from $14.00 to $9.00 and set a “buy” rating on the stock in a report on Wednesday, August 5th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of AdaptHealth in a report on Wednesday, August 19th. Seven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $9.43.

AdaptHealth Trading Down 1.1%

Shares of NASDAQ:AHCO opened at $7.33 on Friday. AdaptHealth has a 1 year low of $5.21 and a 1 year high of $13.43. The firm has a market capitalization of $999.37 million, a price-to-earnings ratio of -2.44 and a beta of 1.36. The company has a debt-to-equity ratio of 1.53, a current ratio of 1.13 and a quick ratio of 0.98. The business’s 50 day moving average price is $6.00 and its 200-day moving average price is $9.07.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported ($1.13) EPS for the quarter, missing the consensus estimate of ($0.05) by ($1.08). The company had revenue of $745.65 million during the quarter, compared to analysts’ expectations of $725.87 million. AdaptHealth had a negative return on equity of 0.27% and a negative net margin of 12.90%. AdaptHealth’s revenue was down 9.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.16 EPS.

Institutional Investors Weigh In On AdaptHealth

Large investors have recently modified their holdings of the business. Principal Financial Group Inc. lifted its holdings in shares of AdaptHealth by 25.1% in the 1st quarter. Principal Financial Group Inc. now owns 2,784,316 shares of the company’s stock worth $33,133,000 after acquiring an additional 558,357 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of AdaptHealth by 8.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 6,920,973 shares of the company’s stock worth $82,353,000 after purchasing an additional 518,274 shares during the period. Lazard Asset Management LLC boosted its position in shares of AdaptHealth by 35.0% during the 1st quarter. Lazard Asset Management LLC now owns 1,669,454 shares of the company’s stock worth $19,867,000 after purchasing an additional 432,664 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in AdaptHealth by 87.7% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 847,085 shares of the company’s stock valued at $10,080,000 after purchasing an additional 395,668 shares during the last quarter. Finally, Corient Private Wealth LP increased its holdings in AdaptHealth by 259.0% in the 2nd quarter. Corient Private Wealth LP now owns 224,099 shares of the company’s stock valued at $2,335,000 after purchasing an additional 161,677 shares during the last quarter. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth Corp. (NASDAQ: AHCO) is a provider of home medical equipment, supplies and related healthcare services in the United States. The company helps patients manage chronic conditions and recover from illness or injury outside of traditional healthcare facilities, working with individuals, caregivers, physicians and payers.

Its products and services include respiratory equipment and supplies, oxygen therapy, sleep therapy devices such as continuous positive airway pressure systems, diabetes management products, mobility and accessibility equipment, and other durable medical equipment.